{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:40:29Z","timestamp":1785498029365,"version":"3.56.0"},"reference-count":20,"publisher":"American Animal Hospital Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    The triazole antifungal itraconazole may be cost prohibitive in brand name form; therefore, compounded and generic products are often used as alternatives. Itraconazole blood concentrations have not been studied in clinical patients receiving these formulations. Itraconazole bioassay was performed on serum\/plasma from 95 dogs and 20 cats receiving itraconazole (compounded from bulk powder, generic pelletized, or brand name) for systemic mycosis treatment. Mean itraconazole concentration was lower in the compounded group (\n                    <jats:italic>n<\/jats:italic>\n                    = 42) as compared with the generic (\n                    <jats:italic>n<\/jats:italic>\n                    = 40) or brand name (\n                    <jats:italic>n<\/jats:italic>\n                    = 33) groups (0.5 \u00b5g\/mL versus 8.3 \u00b5g\/mL and 6.5 \u00b5g\/mL, respectively;\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .001). No statistical difference was observed between itraconazole concentrations in the generic and brand name groups. Forty animals (95.2%) in the compounded group had subtherapeutic (&lt;1.0 \u00b5g\/mL) values. All cats in this group (\n                    <jats:italic>n<\/jats:italic>\n                    = 10) had undetectable itraconazole concentrations. Some animals in the generic and brand name groups had subtherapeutic values (12.5 and 12.1%, respectively) or potentially toxic values (&gt;10 \u00b5g\/mL; 37.5 and 24%, respectively). Compounded itraconazole should be avoided, but generic itraconazole appears to serve as a reasonable alternative to brand name itraconazole. Therapeutic drug monitoring may be beneficial in all cases.\n                  <\/jats:p>","DOI":"10.5326\/jaaha-ms-6591","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T12:13:11Z","timestamp":1526299991000},"page":"195-200","source":"Crossref","is-referenced-by-count":26,"title":["Comparison of Compounded, Generic, and Innovator-Formulated Itraconazole in Dogs and Cats"],"prefix":"10.5326","volume":"54","author":[{"given":"Janelle","family":"Renschler","sequence":"first","affiliation":[{"name":"From MiraVista Diagnostics, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Albers","sequence":"additional","affiliation":[{"name":"From MiraVista Diagnostics, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sinclair-Mackling","sequence":"additional","affiliation":[{"name":"From MiraVista Diagnostics, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence Joseph","family":"Wheat","sequence":"additional","affiliation":[{"name":"From MiraVista Diagnostics, Indianapolis, Indiana."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3280","reference":[{"key":"bib1","article-title":"Titusville (NJ): Janssen Pharmaceuticals, Inc.","year":"2014","unstructured":"Sporanox (itraconazole) capsules (package insert). Titusville (NJ): Janssen Pharmaceuticals, Inc.; 2014."},{"issue":"4","key":"bib2","series-title":"Antimicrob Agents Chemother","first-page":"778","article-title":"Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers","volume":"37","author":"Barone\n              JA","year":"1993","unstructured":"Barone\n              JA\n            , KohJG, BiermanRH, et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob Agents Chemother1993;37(4):778\u201384."},{"issue":"7","key":"bib3","series-title":"Antimicrob Agents Chemother","first-page":"1862","article-title":"Enhanced bioavailability of itraconazole in hydroxypropyl-b-cyclodextrin solution versus capsules in healthy volunteers","volume":"42","author":"Barone\n              JA","year":"1998","unstructured":"Barone\n              JA\n            , MoskovitzJL, GuarnieriJ, et al. Enhanced bioavailability of itraconazole in hydroxypropyl-b-cyclodextrin solution versus capsules in healthy volunteers. Antimicrob Agents Chemother1998;42(7):1862\u20135."},{"key":"bib4","article-title":"Pharmacist FAQs: Should I compound itraconazole? North Carolina Board of Pharmacy","author":"Davidson\n              G","unstructured":"Davidson\n              G\n            \n          . Pharmacist FAQs: Should I compound itraconazole? North Carolina Board of Pharmacy. Available at: www.ncbop.org\/faqs\/Pharmacist\/faq_CompoundingItraconazole.htm. Accessed April 27, 2015."},{"issue":"1","key":"bib5","series-title":"J Zoo Wildlife Med","first-page":"127","article-title":"Cryptococcus gattii osteomyelitis and compounded itraconazole treatment failure in a Pesquet's parrot (Psittrichas fulgidus)","volume":"45","author":"Molter\n              CM","year":"2014","unstructured":"Molter\n              CM\n            , ZubaJR, PapendickR. Cryptococcus gattii osteomyelitis and compounded itraconazole treatment failure in a Pesquet's parrot (Psittrichas fulgidus). J Zoo Wildlife Med2014;45(1):127\u201333."},{"issue":"3","key":"bib6","series-title":"J Zoo Wildlife Med","first-page":"487","article-title":"Effects of compounding on pharmacokinetics of itraconazole in black-footed penguins (Speniscus demersus)","volume":"41","author":"Smith\n              JA","year":"2010","unstructured":"Smith\n              JA\n            , PapichMG, RussellG, et al. Effects of compounding on pharmacokinetics of itraconazole in black-footed penguins (Speniscus demersus). J Zoo Wildlife Med2010;41(3):487\u201395."},{"issue":"1","key":"bib7","series-title":"J Vet Intern Med","first-page":"72","article-title":"Bioequivalence of orally administered generic, compounded, and innovator-formulated itraconazole in healthy dogs","volume":"28","author":"Mawby\n              DI","year":"2014","unstructured":"Mawby\n              DI\n            , WhittemoreJC, GengerS, et al. Bioequivalence of orally administered generic, compounded, and innovator-formulated itraconazole in healthy dogs. J Vet Intern Med2014;28(1):72\u20137."},{"issue":"6","key":"bib8","series-title":"J Vet Intern Med","first-page":"365","article-title":"Treatment of blastomycosis with itraconazole in 112 dogs","volume":"10","author":"Legendre\n              AM","year":"1996","unstructured":"Legendre\n              AM\n            , RohrbachBW, ToalRL, et al. Treatment of blastomycosis with itraconazole in 112 dogs. J Vet Intern Med1996;10(6):365\u201371."},{"key":"bib9","series-title":"Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents","first-page":"223","article-title":"The pharmacokinetics of itraconazole in animals and man: an overview","author":"Heykants\n              J","year":"1987","unstructured":"Heykants\n              J\n            , MichielsJM, MeuldermansW, et al. The pharmacokinetics of itraconazole in animals and man: an overview. In: FromtlingRA, ed. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents. Barcelona (Spain): J.R. Prous; 1987:223\u201349."},{"issue":"10","key":"bib10","series-title":"Arch Intern Med","first-page":"2301","article-title":"Itraconazole therapy for cryptococcal meningitis and cryptococcosis","volume":"149","author":"Denning\n              DW","year":"1989","unstructured":"Denning\n              DW\n            , TuckerRM, HansonLH, et al. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med1989;149(10):2301\u20138."},{"issue":"7\u20138","key":"bib11","series-title":"Mycoses","first-page":"443","article-title":"Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole","volume":"42","author":"Glasmacher\n              A","year":"1999","unstructured":"Glasmacher\n              A\n            , HahnC, LeutnerC, et al. Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole. Mycoses1999;42(7\u20138):443\u201351."},{"issue":"2","key":"bib12","series-title":"Clin Infect Dis","first-page":"235","article-title":"Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards","volume":"24","author":"Rex\n              JH","year":"1997","unstructured":"Rex\n              JH\n            , PfallerMA, GalgianiJN, et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis1997;24(2):235\u201347."},{"issue":"7","key":"bib13","series-title":"Antimicrob Agents Chemother","first-page":"1561","article-title":"Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards","volume":"38","author":"Law\n              D","year":"1994","unstructured":"Law\n              D\n            , MooreCB, DenningDW. Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards. Antimicrob Agents Chemother1994;38(7):1561\u20136."},{"issue":"5","key":"bib14","series-title":"J Antimicrob Chemother","first-page":"723","article-title":"Bioassays for itraconazole blood levels: an interlaboratory collaborative study","volume":"43","author":"Odds\n              FC","year":"1999","unstructured":"Odds\n              FC\n            , DupontB, RinaldiMG, et al. Bioassays for itraconazole blood levels: an interlaboratory collaborative study. J Antimicrob Chemother1999;43(5):723\u20137."},{"issue":"6","key":"bib15","series-title":"Clin Infect Dis","first-page":"928","article-title":"Toxicodynamics of itraconazole: implications for therapeutic drug monitoring","volume":"49","author":"Lestner\n              JM","year":"2009","unstructured":"Lestner\n              JM\n            , RobertsSA, MooreCB, et al. Toxicodynamics of itraconazole: implications for therapeutic drug monitoring. Clin Infect Dis2009;49(6):928\u201330."},{"key":"bib16","series-title":"Antimicrobial Drug Formulary: Itraconazole","first-page":"1268","author":"Greene\n              CE","year":"2012","unstructured":"Greene\n              CE\n            , CalpinJ. Antimicrobial Drug Formulary: Itraconazole. In: GreeneCE, ed. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis: Elsevier; 2012:1268\u201370."},{"key":"bib17","article-title":"Compounding of drugs for use in animals. Guidance for FDA staff and industry: Compliance Policy Guides manual, Sec.608.400","year":"2003","unstructured":"United States Food and Drug Administration. Compounding of drugs for use in animals. Guidance for FDA staff and industry: Compliance Policy Guides manual, Sec.608.400; Rockville (MD): FDA; 2003."},{"key":"bib18","article-title":"Policies: Compounding from unapproved (bulk) substances in non-food animals","author":"AVMA","unstructured":"AVMA\n            \n          \n          Policies: Compounding from unapproved (bulk) substances in non-food animals. American Veterinary Medical Association. Available at: www.avma.org\/KB\/Policies\/Pages\/Compounding-from-Unapproved-Bulk-Substances-in-Non-Food-Animals.aspx. Accessed April 29, 2015."},{"issue":"1","key":"bib19","series-title":"J Vet Pharmacol Therap","first-page":"27","article-title":"Alternate-day dosing of itraconazole in healthy adult cats","volume":"39","author":"Middleton\n              SM","year":"2016","unstructured":"Middleton\n              SM\n            , KubierA, DirklouL, et al. Alternate-day dosing of itraconazole in healthy adult cats. J Vet Pharmacol Therap2016;39(1):27\u201331."},{"issue":"4","key":"bib20","series-title":"Am J Med","first-page":"336","article-title":"Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome","volume":"98","author":"Wheat\n              J","year":"1995","unstructured":"Wheat\n              J\n            , HafnerR, KorzunAH, et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med1995;98(4):336\u201342."}],"container-title":["Journal of the American Animal Hospital Association"],"original-title":[],"link":[{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/54\/4\/article-p195.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jaaha\/article-pdf\/54\/4\/195\/1589834\/jaaha-ms-6591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/54\/4\/article-p195.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jaaha.kglmeridian.com\/downloadpdf\/journals\/aaha\/54\/4\/article-p195.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:02:52Z","timestamp":1763740972000},"score":1,"resource":{"primary":{"URL":"https:\/\/jaaha.kglmeridian.com\/view\/journals\/aaha\/54\/4\/article-p195.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":20,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5326\/jaaha-ms-6591","relation":{},"ISSN":["0587-2871","1547-3317"],"issn-type":[{"value":"0587-2871","type":"print"},{"value":"1547-3317","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}